Psychiatry and Behavioral Health

Latest News

How Magellan’s Behavior Health Program Saved up to $4,300 PMPY
How Magellan’s Behavior Health Program Saved up to $4,300 PMPY

November 7th 2023

Using an AI platform, Magellan Health was able to better support providers in prescribing behavioral health medications and addressing medication problems, which reduced pharmacy costs and increased adherence.

FDA Approves Extended-Release Therapy for Major Depression
FDA Approves Extended-Release Therapy for Major Depression

September 28th 2023

FDA Accepts NDA for Zuranolone for Depression
FDA Accepts NDA for Zuranolone for Depression

February 6th 2023

FDA Approves Vraylar for Major Depressive Disorder
FDA Approves Vraylar for Major Depressive Disorder

December 20th 2022

EmpiRx Health Lowers Drug Spend in Mental Health
EmpiRx Health Lowers Drug Spend in Mental Health

October 7th 2022

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.